common glp 1 agonist GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease The GLP-1 Agonists and Obesity:
Description
The majority of GLP-1 medications are only approved for adults 18 years and older
These include Semaglutide, Liraglutide, and Lixisenatide
There are clinical trials evaluating if these GLP-1 and multi-agonists can address neurodegeneration, addiction, inflammation, and beyond
Reactive Oxygen Species and Antioxidant Defense in Puromycin Aminonucleoside Glomerulopathy
doi:10.1111/j.1365-2982.2008.01246.x Amato A, Cinci L, Rotondo A, et al
